OTE/SPH OTE/SPH
JWBK126-15 JWBK126-Kerry March 18, 2008 13:34 Char Count= 0
264 Smart Packaging Technologies for Fast Moving Consumer Goods
Over the years, the healthcare and pharmaceutical industries have devoted much effort
to the development of packaging delivery systems that aid compliance. A significant trend
has been towards the blister pack, with the assumption that this form of convenient pack-
aging with intuitive graphics can improve medication compliance, but without remind and
record functionality, only limited improvements are possible. Smart packaging technolo-
gies are now emerging with these improved functionalities, including the tracking of actual
medication use and communication with the healthcare provider.
A further area affecting non-compliance is the difficulty many people have in reading
or understanding the contents and instructions of prescription medications. The small print
and look-alike packaging of medicine vials can lead to confusion and mistakes, particularly
in those with sight impairments, dyslexia, or reading problems. Many people want the
packaging to explain more clearly how a drug works, suggesting that it would probably
be beneficial if the pack used visual rather than text-based instructions and explanations.
Improved on-pack communication will be one of the principal features of electronic smart
packaging. Branded pharmaceutical packaging with built-in smart features such as moving
colour images accompanied by a sound track in the language of choice could have a dramatic
effect on assisting the old and infirm to take their medication, help encourage compliance
and make it harder for generics to copy a product.
Authenticity. Authentication issues are – for obvious reasons – even more important with
pharmaceuticals than they are with food and beverages. The World Health Organization
estimates that counterfeit drugs cost the pharmaceutical industry $40 billion yearly and the
US government has already issued guidelines for the use of electronic pedigree systems for
the pharmaceutical supply chain. These systems may use RFIDs or bar codes on item-level
packaging that record the details of every transfer by wholesalers and re-packagers, until
the final sale or use of the drug. Alarmed by the increasing cases of fake Viagra, Pfizer
has announced in January 2006 that it will use RFID tags on all Viagra bottles in the US
to authenticate the products. The subject of RFID on packaging and authenticity is an
important subject in its own right but lies outside of the scope of this chapter.
Authenticity is key to the market branding of leading products, and the issue of product
counterfeiting has long been a problem for certain luxury and high-end consumer products.
Smart RFID tags confirming product authenticity, and other difficult-to-copy technologies
offering high security, will become commonplace, initially in combating stock loss of high
value products, such as spirits and perfume.
‘Health in the Home’ Concepts. Future growth opportunities exist in ‘health in the home’
concepts, where low-cost, convenience, portability and ease-of-use will drive the develop-
ment of smarter packaging and product delivery devices, empowering people to take more
responsibility for the state of their health. The challenge will be to develop new meth-
ods of diagnosing or predicting illness early, in order to prevent or reduce the subsequent
costs of diagnosis and treatment. Smart medical packaging will give the consumer greater
control and the ability to easily, accurately and quickly personally monitor their condi-
tion in the home. In the longer term, the integration of health information provision and
monitoring will enable individuals to become custodians of their health and that of their
families.